Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 332.00
-2.50 (-0.75%)
Jul 24, 2026, 5:35 PM CET
Virbac Revenue
In the year 2025, Virbac had annual revenue of 1.46B EUR with 4.81% growth. Virbac had revenue of 726.40M in the half year ending December 31, 2025, with 14.14% growth.
Revenue
1.46B
Revenue Growth
+4.81%
P/S Ratio
1.90
Revenue / Employee
227.36K
Employees
6,442
Market Cap
2.78B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 67.28M | 4.81% |
| Dec 31, 2024 | 1.40B | 150.50M | 12.07% |
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | 934.20M | -4.14M | -0.44% |
| Dec 31, 2019 | 938.34M | 69.41M | 7.99% |
| Dec 31, 2018 | 868.93M | 7.05M | 0.82% |
| Dec 31, 2017 | 861.88M | -9.95M | -1.14% |
| Dec 31, 2016 | 871.83M | 19.21M | 2.25% |
| Dec 31, 2015 | 852.62M | 79.51M | 10.28% |
| Dec 31, 2014 | 773.12M | 37.04M | 5.03% |
| Dec 31, 2013 | 736.08M | 40.93M | 5.89% |
| Dec 31, 2012 | 695.16M | 72.10M | 11.57% |
| Dec 31, 2011 | 623.06M | 50.23M | 8.77% |
| Dec 31, 2010 | 572.83M | 105.41M | 22.55% |
| Dec 31, 2009 | 467.42M | 24.06M | 5.43% |
| Dec 31, 2008 | 443.36M | 4.81M | 1.10% |
| Dec 31, 2007 | 438.55M | 36.91M | 9.19% |
| Dec 31, 2006 | 401.64M | 29.23M | 7.85% |
| Dec 31, 2005 | 372.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| emeis Société anonyme | 5.90B |
| Ramsay Générale de Santé | 5.36B |
| Clariane SE | 5.31B |
| bioMérieux | 4.07B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 3.01B |
Virbac News
- 4 days ago - Virbac Earnings release: Q2 2026 - Filings
- 6 weeks ago - Virbac : Declaration of the number of shares and voting rights 05/2026 - GlobeNewsWire
- 2 months ago - Virbac : Declaration of the number of shares and voting rights 04/2026 - GlobeNewsWire
- 3 months ago - Virbac : Public release of Virbac Annual Report at 31 December 2025. - GlobeNewsWire
- 3 months ago - Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms - GlobeNewsWire
- 3 months ago - Virbac Earnings release: Q1 2026 - Filings
- 3 months ago - Virbac : Declaration of the number of shares and voting rights 03/2026 - GlobeNewsWire
- 4 months ago - Virbac Earnings Call Transcript: H2 2025 - Transcripts